PDC and neoplasm: In addition to potentially enabling selective activation within the tumor environment, PDC constructs, and complexes of ADC with anti-idiotypic binding domains, may enhance the ADC’s intra-tumoral distribution, efficacy, and therapeutic index by decreasing the impact of the “binding site barrier” within solid tumors [210,211,212,213].